Showing results (161-170 of 192) with videos related to
Sort By:
Pageof 20
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 23, 2011
Engineering of α-conotoxin MII-derived peptides with increased selectivity for native α6β2* nicotinic acetylcholine receptorsLuca Pucci, Giovanni Grazioso, Clelia Dallanoce, et al.Cellular Signalling|June 9, 2019
Antagonizing α7 nicotinic receptors with methyllycaconitine (MLA) potentiates receptor activity and memory acquisitionNick P van Goethem, Dean Paes, Daniela Puzzo, et al.ACS Chemical Neuroscience|March 6, 2014
Discovery of potent positive allosteric modulators of the α3β2 nicotinic acetylcholine receptor by a chemical space walk in ChEMBLJustus J Bürgi, Mahendra Awale, Silvan D Boss, et al.Proceedings of the National Academy of Sciences of the United States of America|April 29, 2015
Molecular blueprint of allosteric binding sites in a homologue of the agonist-binding domain of the α7 nicotinic acetylcholine receptorRadovan Spurny, Sarah Debaveye, Ana Farinha, et al.Molecular Pharmacology|November 1, 2011
α7β2 nicotinic acetylcholine receptors assemble, function, and are activated primarily via their α7-α7 interfacesTeresa A Murray, Daniel Bertrand, Roger L Papke, et al.The Journal of Pharmacology and Experimental Therapeutics|June 12, 2014
Characterization of RO5126946, a Novel α7 nicotinic acetylcholine receptor-positive allosteric modulatorSunil Sahdeo, Tanya Wallace, Ryoko Hirakawa, et al.Plos One|June 7, 2013
Gating of long-term potentiation by nicotinic acetylcholine receptors at the cerebellum input stageFrancesca Prestori, Claudia Bonardi, Lisa Mapelli, et al.Journal of Medicinal Chemistry|April 1, 2009
Use of acetylcholine binding protein in the search for novel alpha7 nicotinic receptor ligands. In silico docking, pharmacological screening, and X-ray analysisChris Ulens, Atilla Akdemir, Aldo Jongejan, et al.The Journal of Biological Chemistry|January 7, 2012
Dimeric α-cobratoxin X-ray structure: localization of intermolecular disulfides and possible mode of binding to nicotinic acetylcholine receptorsAlexey V Osipov, Prakash Rucktooa, Igor E Kasheverov, et al.British Journal of Pharmacology|December 27, 2019
Fulditoxin, representing a new class of dimeric snake toxins, defines novel pharmacology at nicotinic ACh receptorsChun Shin Foo, Chacko Jobichen, Varuna Hassan-Puttaswamy, et al.Pageof 20